Agni Bio » Team

The Agni team has driven multiple drug approvals using novel antibody modalities that have set new standards of care in oncology and autoimmunity.

Executive Team

John A. Orwin,
MBA

Acting Chief Executive Officer

Matt Lorenzi,
PhD

Chief Scientific Officer

Jessie Richardson,
JD PhD

Chief Operating Officer & General Counsel

Daniel Maslyar,
MD

Chief Medical Officer

Iqbal Grewal,
PhD, DSc, FRCPath

Chief Technical Officer

Karin Thacker,
MSc

Senior Vice President of Regulatory Affairs & Quality

Nataša Obermajer,
MPharm PhD

Vice President of Research & Discovery

Michael Terpstra,
MBA

Vice President of Finance and Commercial Strategy

Board Members

Sanjay Mistry, PhD

Johnson & Johnson Innovation – JJDC

John A. Orwin, MBA

Samsara BioCapital

Srini Akkaraju, MD, PhD

Samsara BioCapital

Matt Lorenzi, PhD

Agni Bio, Inc.

Board Observers

Andres Telles, PhD

Johnson & Johnson Innovation – JJDC

Jake Bieber-Dishart, PhD

Samsara BioCapital

Scientific Advisory Board

Tullia Bruno, PhD

University of Pittsburgh

Bill Robinson, MD, PhD

Stanford University

Tom Gajewski, MD, PhD

University of Chicago

Kwok Wong, MD, PhD

New York University

Antoni Ribas, MD PhD

University of California, Los Angeles